glp-1 drugs news today New Guidelines on for Obesity Released New study out today from

Missing doses can disrupt appetite control and lead to rebound hunger, so maintaining consistency is important

95% CI, 0.73 to 0.92), and death from CV disease by 13% (HR, 0.87

Routine measurement of serum calcitonin levels or thyroid ultrasound screening before starting GLP-1 therapy is not recommended in asymptomatic patients without specific risk factors

If you take levothyroxine (or liothyronine, natural desiccated thyroid, or any thyroid hormone replacement), GLP-1 medications can affect how your body processes that medication in several important ways

Individuals interested in supporting gut microbiome health